Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.51% |
| 2 | Consumer Discretionary | 7.62% |
| 3 | Energy | 7.06% |
| 4 | Technology | 6.57% |
| 5 | Industrials | 5.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JMBA
5126
PUT
DELISTED
Jamba, Inc.
JMBA
| $116K | ﹤0.01% |
+8,700
| New | +$123K |
|
5127
CALL
Diodes
DIOD
$4.48B
| $115K | ﹤0.01% |
4,700
-10,000
| -68% | -$260K |
|
5128
PUT
Geron
GERN
$982M
| $115K | ﹤0.01% |
36,184
+14,918
| +70% | +$24.4K |
|
5129
Lexicon Pharmaceuticals
LXRX
$1.04B
| $115K | ﹤0.01% |
6,928
-61,629
| -90% | -$1.03M |
|
5130
PUT
Nordic American Tanker
NAT
$1.4B
| $115K | ﹤0.01% |
14,310
-3,475
| -20% | -$29K |
|
|
EQM
5131
DELISTED
EQM Midstream Partners, LP
EQM
| $115K | ﹤0.01% |
2,343
-6,091
| -72% | -$286K |
|
|
FUBC
5132
DELISTED
1st United Bancorp (Florida)
FUBC
| $115K | ﹤0.01% |
15,697
+3,747
| +31% | +$28.1K |
|
|
STRZA
5133
PUT
DELISTED
Starz - Series A
STRZA
| $115K | ﹤0.01% |
4,100
-200
| -5% | -$4.93K |
|
5134
Groupon
GRPN
$894M
| $114K | ﹤0.01% |
510
-5,946
| -92% | -$1.18M |
|
|
IGD
5135
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$526M
| $114K | ﹤0.01% |
+12,588
| New | +$118K |
|
5136
PUT
Power Integrations
POWI
$3.48B
| $114K | ﹤0.01% |
4,200
+2,200
| +110% | +$57K |
|
|
RWT
5137
PUT
Redwood Trust
RWT
$599M
| $114K | ﹤0.01% |
5,800
+1,900
| +49% | +$33.8K |
|
5138
UNIFI
UFI
$120M
| $114K | ﹤0.01% |
4,880
-20,369
| -81% | -$466K |
|
|
TRQ
5139
PUT
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $114K | ﹤0.01% |
+3,351
| New | +$132K |
|
|
OSIR
5140
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $114K | ﹤0.01% |
6,873
-17,977
| -72% | -$266K |
|
5141
CALL
Arthur J. Gallagher & Co
AJG
$65B
| $113K | ﹤0.01% |
2,600
+500
| +24% | +$22K |
|
|
DMC
5142
PUT
Del Monte Corp
DMC
$1.44B
| $113K | ﹤0.01% |
+3,800
| New | +$111K |
|
5143
Frontline
FRO
$9.02B
| $113K | ﹤0.01% |
8,518
+6,367
| +296% | +$79.9K |
|
5144
CALL
Independent Bank Corp
IBCP
$854M
| $113K | ﹤0.01% |
+11,300
| New | +$95.5K |
|
5145
CALL
Rithm Capital
RITM
$5.79B
| $113K | ﹤0.01% |
+8,550
| New | +$112K |
|
|
CUTR
5146
DELISTED
Cutera, Inc.
CUTR
| $113K | ﹤0.01% |
12,705
-35,580
| -74% | -$336K |
|
5147
PUT
Barings BDC
BBDC
$987M
| $112K | ﹤0.01% |
3,800
+1,900
| +100% | +$55.3K |
|
5148
Centrus Energy
LEU
$3.83B
| $112K | ﹤0.01% |
966
+640
| +196% | +$90.5K |
|
5149
PUT
Madrigal Pharmaceuticals
MDGL
$11.7B
| $112K | ﹤0.01% |
506
-1,540
| -75% | -$328K |
|
|
XRTX
5150
DELISTED
XYRATEX LTD (BERMUDA)
XRTX
| $112K | ﹤0.01% |
+10,056
| New | +$108K |
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors's Q3 2013 filing shows 735 new, 2,740 increased, 3,074 reduced and 505 closed positions. Its largest new stake was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M. The largest sale was Pfizer, an estimated $245M.
By sector, the portfolio is most concentrated in Financials at 9.5% of assets, down from 11% a quarter earlier, followed by Consumer Discretionary and Energy.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 735 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.